FDA Adverse Event Injury Summary report: N

NOVOSORB BTM

MDR report key: 14838956 · Received June 28, 2022

Report

Report Number
3007886187-2022-00002
Event Type
Injury
Date Received
June 28, 2022
Date of Event
June 21, 2022
Report Date
October 6, 2022
Manufacturer
POLYNOVO BIOMATERIALS PTY LTD
Product Code
FRO
PMA / PMN Number
K172140
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ALTERNATE SURGICAL APPROACH REQUIRED BECAUSE THE BTM HAD NOT SUFFICIENTLY INTEGRATED. FURTHER DETAILS ARE PENDING. DELAYED INTEGRATION BECAUSE OF A LACK OF VIABLE WOUND BED OR OTHER COMPLICATION IS DESCRIBED IN THE IFU. HOWEVER, IN THIS CASE IT IS NOT EXPECTED AS WOUND PREPARATION (BONE BURRING) LOOKS TO HAVE BEEN ADEQUATE.

Additional Manufacturer Narrative · 0

ALTHOUGH THE DEVICE WAS UNAVAILABLE FOR EVALUATION, A REVIEW OF BATCH 190702L5 HAS BEEN CONDUCTED AND NO ERRORS WERE IDENTIFIED.

Description of Event or Problem · 0

IT IS REPORTED THAT BTM HAD NOT (COMPLETELY) INTEGRATED AFTER 7 WEEKS ADDING THAT THERE HAD BEEN BURRING OF THE OUTER TABLE. IT WAS REPORTED THAT A FREE FLAP WAS USED AND LARGE AREAS OF BTM WAS REMOVED. THE REPORTER ALSO STATED THAT HE WAS UNSURE WHY THE BTM HAD NOT INTEGRATED AND COMMENTED THAT THE PATIENT WAS VERY FIT, COMPLIANT AND A NON-SMOKER. EVENT RESOLUTION IS RESOLVED. ACTION TAKEN WITH THE DEVICE WAS AS PARTIALLY REMOVED AND NOT REPLACED.

Description of Event or Problem · 0

THE REPORTER STATED THE INDICATION FOR NOVOSORB BTM USE WAS EXCISION OF A SKIN CANCER, AND THAT THE CAUSE OF DELAY IN INTEGRATION IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1938012 NOVOSORB BTM WOUND DRESSING FRO POLYNOVO BIOMATERIALS PTY LTD BTM-1020 190702L5

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention